| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 19.2. Sera and immunoglobulins | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 19.2. Sera and immunoglobulins | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 19.2. Sera and immunoglobulins | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 11.2.1. Human immunoglobulins | No observations |
| Belize. National Drug Formulary | 19.02 Sera and immunoglobulins | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Haiti. National List of Essential Medicines | 11.02.01 Human immunoglobulins | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 19.2. Sera and immunoglobulins | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Vaccines | No observations |